Human epidermal growth factor receptor 2 (HER2) protein overexpression and/or HER2 gene amplification has a key role in the development and progressing of many carcinomas, especially breast and stomach cancer [3,4], but also in non-small cell lung carcinoma (NSCLC) [5,6]. The gene discussed is ERBB2; the disease is non-small cell lung carcinoma.